| Unique ID issued by UMIN | UMIN000033777 |
|---|---|
| Receipt number | R000038528 |
| Scientific Title | Effects of Bioabsorbable Polymer Drug-Eluting Stents (DES) on Coronary Hyperconstricting Responses After Percutaneous Coronary Intervention in Comparison with Durable Polymer DES - A Randomized Controlled Study - |
| Date of disclosure of the study information | 2018/08/16 |
| Last modified on | 2021/02/16 13:56:26 |
Effects of Bioabsorbable Polymer Drug-Eluting Stents (DES) on Coronary Hyperconstricting Responses After Percutaneous Coronary Intervention in Comparison with Durable Polymer DES - A Randomized Controlled Study -
Effects of Bioabsorbable Polymer Drug-Eluting Stents (DES) on Coronary Hyperconstricting Responses After Percutaneous Coronary Intervention in Comparison with Durable Polymer DES - A Randomized Controlled Study -
Effects of Bioabsorbable Polymer Drug-Eluting Stents (DES) on Coronary Hyperconstricting Responses After Percutaneous Coronary Intervention in Comparison with Durable Polymer DES - A Randomized Controlled Study -
Effects of Bioabsorbable Polymer Drug-Eluting Stents (DES) on Coronary Hyperconstricting Responses After Percutaneous Coronary Intervention in Comparison with Durable Polymer DES - A Randomized Controlled Study -
| Japan |
Ischemic cardio myopathy
| Cardiology |
Others
NO
The purpose of this study is to investigate the effects of bioabsorbable polymer drug-eluting Stents (DES) on coronary hyperconstricting responses after percutaneous coronary intervention in comparison with durable polymer DES
Efficacy
Effects of bioabsorbable polymer drug-eluting stents (DES) on coronary hyperconstricting responses after percutaneous coronary intervention in comparison with durable polymer DES
Interventional
Parallel
Randomized
Cluster
Open -but assessor(s) are blinded
Active
2
Treatment
| Other |
Bioabsorbable polymer Drug-Eluting Stents
Durable polymer DES
| 20 | years-old | <= |
| Not applicable |
Male and Female
Ischemic cardio myopathy
(1)Acute coronary syndrome
(2)EF is under 40%
(3)Chronic Total Occlusion
(4)Severe hepatic and renal failure
(5)Severe acetylcholine allergy
(6)Severe contrast allergy
(7)asthma
100
| 1st name | |
| Middle name | |
| Last name | Hiroaki Shimokawa |
Tohoku University Hospital
Department of Cardiovascular Medicine
1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan
+81-22-717-7153
shimo@cardio.med.tohoku.ac.jp
| 1st name | |
| Middle name | |
| Last name | Yasuharu Matsumoto |
Tohoku University Hospital
Department of Cardiovascular Medicine
1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan
+81-22-717-7153
matsumoto@cardio.med.tohoku.ac.jp
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Japan society for promotion science
Government offices of other countries
NO
| 2018 | Year | 08 | Month | 16 | Day |
Unpublished
Terminated
| 2018 | Year | 08 | Month | 16 | Day |
| 2018 | Year | 08 | Month | 17 | Day |
| 2018 | Year | 08 | Month | 16 | Day |
| 2020 | Year | 04 | Month | 01 | Day |
| 2018 | Year | 08 | Month | 16 | Day |
| 2021 | Year | 02 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038528